Dubai hosted the 2nd Pharmacy Academy Medical Conference on 14 November 2025 at Conrad Dubai, attracting more than 650 in-person participants and over 1,000 virtual attendees from across the region. The event reaffirmed Dubai’s growing role as a leading hub for continuing medical education and pharmaceutical innovation.
The conference was co-chaired by Dr. Yanal Sallam, Consultant in Internal Medicine and Head of the Internal Medicine Department at Emirates Hospital Jumeirah, and Dr. Wael Atef, Head of Pharmacy at Emirates Hospital Jumeirah. In their opening remarks, they emphasized the importance of strengthening the clinical role of pharmacists, supporting medication-safety initiatives, and advancing evidence-based professional practice.
The conference witnessed extensive participation from major global pharmaceutical companies, including Lilly, Abbott, Bayer, Hikma, and AbbVie, along with leading pharmacy chains and health-insurance providers. Exhibitors showcased the latest advances in pharmaceutical therapy, patient-support programs, digital health solutions, and enhanced pharmacy services.
Scientific Program
The scientific agenda featured more than 40 specialized lectures covering a wide range of medical and pharmaceutical topics, including internal medicine, cardiology, endocrinology, gastroenterology, pediatrics, dermatology, ENT, oncology, psychiatry, and clinical pharmacy. Sessions also explored medication-safety updates, strategies for reducing medication errors, the pharmacist’s role in primary care and chronic-disease management, and the impact of digital innovation on pharmacy practice. The conference enabled participants to engage directly with experts through panel discussions and practical workshops designed to enhance knowledge exchange and clinical skills.
Organized by iConference, the event demonstrated a high level of professionalism in planning and execution, reflecting Dubai’s commitment to advancing continuing medical education and supporting scientific platforms in the fields of pharmacy and healthcare.
The conference received strong praise from attendees and participating organizations. Its resounding success confirmed its position as one of the most important specialized scientific events in the field of pharmacy in the Middle East, with expectations for even broader participation in future editions.
Conference Outcomes and Scientific Importance
The conference produced significant outcomes that support the advancement of pharmacy practice, including enhanced collaboration between pharmacists and physicians, the adoption of advanced methodologies for clinical medication assessment, and the updating of medication-safety protocols in alignment with global evidence-based standards. It also recommended expanding the pharmacist’s role in chronic-disease management and improving patient care through integrated models of multidisciplinary practice. The event served as a dynamic platform for exchanging expertise in therapeutic innovation and digital transformation, strengthening the healthcare sector’s readiness to meet global developments. Its scientific value lies in offering a reliable reference for continuous medical education, fostering professional skill development, and supporting ongoing efforts to improve healthcare outcomes and elevate pharmacy services across the region.